Lung Transplant; Complications Clinical Trial
Official title:
Identifying the Optimal Positive End-Expiratory Pressure Level to Ventilate Patients After Bilateral Lung Transplantation
Lung Transplantation (LuTX) is the curative treatment for selected patients with end-stage lung disease. Primary Graft Dysfunction (PGD), a specific form of respiratory failure occurring within the first 72 hours after graft reperfusion, represents the most common complication after LuTX. Actual recommendation regarding management of mechanical ventilation of the lung graft immediately after LuTX are based only on opinion experts and not on clinical trials. Optimization of Positive End-Expiratory Pressure might contribute to both prevention and treatment of PGD. In this interventional single-center non-pharmacological study (with medical device), in the immediate postoperative period of patients who are undergone LuTX, we will evaluate the effects of varying levels of PEEP upon: - lung and chest wall mechanics, - intrapulmonary shunt fraction; - distribution of ventilation and perfusion; - gas exchange. The final aim is to find the optimal level of PEEP in this patient's cohort
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05526950 -
Cytokine Filtration in Lung Transplantation: A Swedish National Study (GLUSorb)
|
N/A | |
| Recruiting |
NCT05916495 -
An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant
|
N/A | |
| Enrolling by invitation |
NCT05950724 -
RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
|
Early Phase 1 | |
| Active, not recruiting |
NCT05505422 -
Routine Versus Selective Intraoperative ECMO in Lung Transplant
|
N/A | |
| Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
| Enrolling by invitation |
NCT04522388 -
Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant
|
N/A | |
| Completed |
NCT04165161 -
Performance Diagnosis of a Patent Foramen Ovale During Lung Transplantation Using Transesophageal Echocardiography
|
N/A | |
| Recruiting |
NCT05050955 -
AlloSure Lung Assessment and Metagenomics Outcomes Study
|
||
| Withdrawn |
NCT03258801 -
Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis
|
||
| Completed |
NCT04892719 -
4DX Functional Lung Imaging in the Diagnosis of Chronic Lung Allograft Dysfunction After Lung Transplantation
|
N/A | |
| Completed |
NCT03221764 -
Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients
|
Phase 2 | |
| Active, not recruiting |
NCT04975607 -
Live Music Therapy to Reduce Anxiety, Pain and Improve Sleep in Post-Operative Lung Transplant Patients: A Pilot Study
|
N/A | |
| Completed |
NCT05116748 -
COVID19 Vaccine in SOT Adult Recipients
|
||
| Recruiting |
NCT03367221 -
Physiological Response in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist
|
N/A | |
| Recruiting |
NCT03276403 -
Primary Graft Dysfunction Score in Lung Transplantation
|
N/A | |
| Active, not recruiting |
NCT03656926 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)
|
Phase 3 | |
| Completed |
NCT05242289 -
Cytokine Adsorption in Lung Transplantation
|
N/A | |
| Recruiting |
NCT04837339 -
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
|
N/A | |
| Not yet recruiting |
NCT04377139 -
Management of Cytomegalovirus (CMV) Infection in Lung Transplant Recipients (LTR)
|
||
| Not yet recruiting |
NCT06399302 -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
|